In 2024, the FDA approved at-home blood and stool tests for colorectal cancer screenings. In October, a second iteration of the at-home stool test was approved. While new, less-invasive blood tests ...
A study from researchers in Denmark found that younger patients with colorectal cancer were more likely to relapse than older patients, and it took less time for the disease to recur.